HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

XXL Impressions Supplement Memory Claims Impress FTC As False

This article was originally published in The Rose Sheet

Executive Summary

FTC announces agreements to settle complaints against six of nine defendants identified in an investigation of XXL Impressions' advertising for CogniPrin promoted for cognitive benefits and FlexiPrin product promoted to reduce joint paint and rebuild damaged joints and cartilage.

Advertisement

Related Content

FDA Prioritizes Vinpocetine Decison After Animal Study Shows 'Developmental Toxicity'
UAS Labs Expands Probioitic Portfolio: Health And Wellness Industry News
Health And Wellness Industry Regulatory And Litigation News
FTC Could Open Arms For Health Claim Science In Regulatory Review
New York AG And FTC Target Prevagen Memory Claims

Topics

Advertisement
UsernamePublicRestriction

Register

RS109100

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel